Bayesian Capital Management’s Sanofi SNY Stock Holding History

Bayesian Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$307K	Buy	+7,199	New	+$322K	0.2%	150
2025 Q2	–	Sell	-16,183	Closed	-$898K	–	849
2025 Q1	$898K	Sell	16,183 -22,700	-58%	-$1.23M	0.15%	189
2024 Q4	$1.88M	Buy	+38,883	New	+$1.98M	0.23%	133
2022 Q3	–	Sell	-5,489	Closed	-$275K	–	998
2022 Q2	$275K	Sell	5,489 -48,500	-90%	-$2.57M	0.05%	510
2022 Q1	$2.77M	Buy	53,989 +42,166	+357%	+$2.18M	0.41%	36
2021 Q4	$592K	Sell	11,823 -5,350	-31%	-$265K	0.19%	159
2021 Q3	$828K	Buy	+17,173	New	+$873K	0.24%	109
2021 Q2	–	Sell	-5,074	Closed	-$251K	–	627
2021 Q1	$251K	Buy	+5,074	New	+$244K	0.06%	395
2020 Q2	–	Sell	-12,683	Closed	-$555K	–	761
2020 Q1	$555K	Buy	12,683 +7,400	+140%	+$354K	0.12%	265
2019 Q4	$265K	Sell	5,283 -3,917	-43%	-$183K	0.05%	460
2019 Q3	$426K	Buy	9,200 +376	+4%	+$16.2K	0.08%	308
2019 Q2	$382K	Buy	8,824 +3,700	+72%	+$157K	0.08%	314
2019 Q1	$227K	Sell	5,124 -368	-7%	-$15.8K	0.04%	447
2018 Q4	$238K	Buy	+5,492	New	+$242K	0.05%	475
2017 Q1	–	Sell	-19,085	Closed	-$772K	–	673
2016 Q4	$772K	Buy	+19,085	New	+$752K	0.19%	196

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bayesian Capital Management's SNY Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in Sanofi (SNY) in Q2 2026: 7,199 shares worth $307K. The stake represents 0.2% of the portfolio and ranks #150 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in SNY as recently as Q1 2025.

Bayesian Capital Management first reported a position in SNY in Q4 2016 and has held it in 15 quarters since. The position peaked at $2.77M in Q1 2022. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Bayesian Capital Management held 7,199 shares of Sanofi worth $307K as of Q2 2026.
Sanofi was a new Bayesian Capital Management position in Q2 2026.
Sanofi made up 0.2% of Bayesian Capital Management's portfolio in Q2 2026, its #150 holding.
Bayesian Capital Management first reported a position in Sanofi in Q4 2016 and has held it in 15 quarters since.
Bayesian Capital Management's Sanofi position peaked at $2.77M in Q1 2022.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.